{"id":7859,"date":"2026-05-01T19:23:42","date_gmt":"2026-05-01T13:53:42","guid":{"rendered":"https:\/\/www.entrepreneurindia.co\/blogs\/?p=7859"},"modified":"2026-05-01T19:23:42","modified_gmt":"2026-05-01T13:53:42","slug":"india-biosimilars-market","status":"publish","type":"post","link":"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/","title":{"rendered":"India Biosimilars Market: A $1.5 Billion Opportunity for Pharma Startups &#038; MSMEs"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"7859\" class=\"elementor elementor-7859\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2e095a7 e-flex e-con-boxed e-con e-parent\" data-id=\"2e095a7\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b401919 elementor-widget elementor-widget-text-editor\" data-id=\"b401919\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Introduction: India Biosimilars Market<\/strong><\/p><p>India has now graduated from being merely &#8220;the pharmacy of the world&#8221; for generic medicines to also becoming the most favoured country to manufacture high-value, complex drugs \u2013 especially, biosimilars. As the market is set to surpass $1.5 billion by 2030, biosimilars are emerging as a lucrative business opportunity in the pharmaceutical industry.<\/p><p>Biosimilars are biological medicines that are &#8216;similar&#8217; to already-approved biologics. They are used for treating cancer, diabetes and autoimmune disorders. The use of biosimilars has seen a significant uptake worldwide because they are more cost-effective than the original biologics.<\/p><p>India is currently producing 35% of the world&#8217;s biosimilars, which indicates its presence in this market.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6ddff3c elementor-widget elementor-widget-text-editor\" data-id=\"6ddff3c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Get_Detailed_Insights_from_This_Book_India_API_Market_Report_2027_Forecast\" >Get Detailed Insights from This Book: India API Market Report (2027 Forecast)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Global_Market_Growth_and_Why_It_Matters\" >Global Market Growth and Why It Matters<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#High-Profit_Segments_You_Should_Know\" >High-Profit Segments You Should Know<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Key_high-value_segments_include\" >Key high-value segments include:<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Get_Detailed_Project_Report_DPR_Market_Research_Report_on_India_Active_Pharmaceutical_Ingredient_API\" >Get Detailed Project Report (DPR): Market Research Report on India Active Pharmaceutical Ingredient (API)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Demand%E2%80%93Supply_Gap_Where_the_Real_Opportunity_Lies\" >Demand\u2013Supply Gap: Where the Real Opportunity Lies<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Major_opportunity_areas\" >Major opportunity areas:<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Investment_Opportunities_for_Entrepreneurs\" >Investment Opportunities for Entrepreneurs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Popular_investment_options_include\" >Popular investment options include:<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Government_Support_Is_a_Big_Advantage\" >Government Support Is a Big Advantage<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Key_government_support_includes\" >Key government support includes:<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Identify_high-growth_industries_before_others_do\" >Identify high-growth industries before others do<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#How_Niir_Project_Consultancy_Services_Helps_You_Start\" >How Niir Project Consultancy Services Helps You Start<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#They_offer_full_range_services_including\" >They offer full range services including:<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Related_Article_Biopharma_SHAKTI_Scheme_Explained_%E2%82%B910000_Crore_Government_Push_for_Biologics_Manufacturing\" >Related Article: Biopharma SHAKTI Scheme Explained: \u20b910,000 Crore Government Push for Biologics Manufacturing<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Future_Outlook_Why_You_Should_Act_Now\" >Future Outlook: Why You Should Act Now<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#Conclusion\" >Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/www.entrepreneurindia.co\/blogs\/india-biosimilars-market\/#FAQs\" >FAQs<\/a><\/li><\/ul><\/nav><\/div>\n<h3 style=\"text-align: center;\"><span class=\"ez-toc-section\" id=\"Get_Detailed_Insights_from_This_Book_India_API_Market_Report_2027_Forecast\"><\/span>Get Detailed Insights from This Book: <a href=\"https:\/\/www.niir.org\/books\/book\/india-active-pharmaceutical-ingredient-api-market-growth-rate-covid-19-impact-economic-impact-size-share-trend-drivers-competitive-landscape-opportunity-forecast-upto-2027\/isbn-9788194737902\/zb,,18bcf,a,0,0,a\/index.html\" rel=\"nofollow noopener\" target=\"_blank\">India API Market Report (2027 Forecast)<\/a><span class=\"ez-toc-section-end\"><\/span><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-349fdb9 e-flex e-con-boxed e-con e-parent\" data-id=\"349fdb9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-388ce77 elementor-widget elementor-widget-heading\" data-id=\"388ce77\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"Global_Market_Growth_and_Why_It_Matters\"><\/span>Global Market Growth and Why It Matters<span class=\"ez-toc-section-end\"><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a35c575 elementor-widget elementor-widget-text-editor\" data-id=\"a35c575\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The biosimilars market is growing fast. The market is estimated to expand from $36.5 billion in 2023 to exceed $100 billion by 2030. This expansion is mainly being driven by the expiring patents of a couple of block-buster biologic drugs and the increasing demand for cost-effective drugs.<\/p><p>India is at an advantage because it can manufacture these drugs cost-effectively as well and the combined presence of its high-skilled manpower and a rapidly advancing regulatory framework allows Indian firms to export biosimilars to Europe, USA and Asia.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-3bf7157 e-flex e-con-boxed e-con e-parent\" data-id=\"3bf7157\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-691f056 elementor-widget elementor-widget-heading\" data-id=\"691f056\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"High-Profit_Segments_You_Should_Know\"><\/span>High-Profit Segments You Should Know<span class=\"ez-toc-section-end\"><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-124c721 elementor-widget elementor-widget-text-editor\" data-id=\"124c721\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Not all biosimilar markets are created equal. There are clearly more profitable and scalable segments.<\/p><p>Monoclonal antibodies-used in the treatment of cancer and autoimmune diseases are the most profitable segment. But these are extremely complex products. They do offer huge profits.<\/p><p>The other key segment is insulin biosimilars. The high and steady demand for insulin due to the increasing number of diabetes patients is a good starting point.<\/p><p>Other segments like erythropoietin, G-CSF are more crowded but still lucrative, particularly for government supply.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-81da7b3 elementor-widget elementor-widget-heading\" data-id=\"81da7b3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"Key_high-value_segments_include\"><\/span>Key high-value segments include:<span class=\"ez-toc-section-end\"><\/span><\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3e5497b elementor-widget elementor-widget-text-editor\" data-id=\"3e5497b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Monoclonal antibodies (oncology, autoimmune diseases)<\/li><li>Insulin and insulin analogues<\/li><li>Fusion proteins and specialty biologics<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1bb8594 elementor-widget elementor-widget-text-editor\" data-id=\"1bb8594\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3 style=\"text-align: center;\" data-start=\"137\" data-end=\"177\"><span class=\"ez-toc-section\" id=\"Get_Detailed_Project_Report_DPR_Market_Research_Report_on_India_Active_Pharmaceutical_Ingredient_API\"><\/span><strong data-start=\"140\" data-end=\"177\">Get Detailed Project Report (DPR): <\/strong><a href=\"https:\/\/www.niir.org\/profile-project-reports\/profile\/4681\/market-research-report-on-india-active-pharmaceutical-ingredient-api.html\" rel=\"nofollow noopener\" target=\"_blank\">Market Research Report on India Active Pharmaceutical Ingredient (API)<\/a><span class=\"ez-toc-section-end\"><\/span><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0b566d0 elementor-widget elementor-widget-image\" data-id=\"0b566d0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"687\" height=\"1024\" src=\"https:\/\/www.entrepreneurindia.co\/blogs\/wp-content\/uploads\/2026\/05\/Gemini_Generated_Image_a0439ua0439ua043-687x1024.png\" class=\"attachment-large size-large wp-image-7864\" alt=\"India Biosimilars Market\" srcset=\"https:\/\/www.entrepreneurindia.co\/blogs\/wp-content\/uploads\/2026\/05\/Gemini_Generated_Image_a0439ua0439ua043-687x1024.png 687w, https:\/\/www.entrepreneurindia.co\/blogs\/wp-content\/uploads\/2026\/05\/Gemini_Generated_Image_a0439ua0439ua043-201x300.png 201w, https:\/\/www.entrepreneurindia.co\/blogs\/wp-content\/uploads\/2026\/05\/Gemini_Generated_Image_a0439ua0439ua043-768x1145.png 768w, https:\/\/www.entrepreneurindia.co\/blogs\/wp-content\/uploads\/2026\/05\/Gemini_Generated_Image_a0439ua0439ua043-150x224.png 150w, https:\/\/www.entrepreneurindia.co\/blogs\/wp-content\/uploads\/2026\/05\/Gemini_Generated_Image_a0439ua0439ua043-750x1118.png 750w, https:\/\/www.entrepreneurindia.co\/blogs\/wp-content\/uploads\/2026\/05\/Gemini_Generated_Image_a0439ua0439ua043.png 848w\" sizes=\"(max-width: 687px) 100vw, 687px\" data-full-width=\"848\" data-full-height=\"1264\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-fcee4b4 e-flex e-con-boxed e-con e-parent\" data-id=\"fcee4b4\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-78405d3 elementor-widget elementor-widget-heading\" data-id=\"78405d3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"Demand%E2%80%93Supply_Gap_Where_the_Real_Opportunity_Lies\"><\/span>Demand\u2013Supply Gap: Where the Real Opportunity Lies<span class=\"ez-toc-section-end\"><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-618969d elementor-widget elementor-widget-text-editor\" data-id=\"618969d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>While the country has strong growth in biosimilars, there are gaps in the ecosystem. These are opportunities for entrepreneurs.<\/p><p>First, access for patients. High potency biosimilars are not always affordable or accessible in India.<\/p><p>Another issue is a reliance on imports for inputs. Many biologic components, like cell culture media and purification resins, are imported.<\/p><p>The cold chain is also poorly developed, particularly in tier 2 and 3 cities, limiting supply.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-297cc38 elementor-widget elementor-widget-heading\" data-id=\"297cc38\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"Major_opportunity_areas\"><\/span>Major opportunity areas:<span class=\"ez-toc-section-end\"><\/span><\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-27ba714 elementor-widget elementor-widget-text-editor\" data-id=\"27ba714\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Local production of biologic inputs<\/li><li>Cost effective biosimilar distribution models<\/li><li>Cold chain services for Tier-2 and Tier-3 cities<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-9417b85 e-flex e-con-boxed e-con e-parent\" data-id=\"9417b85\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-aa4b9d6 elementor-widget elementor-widget-heading\" data-id=\"aa4b9d6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"Investment_Opportunities_for_Entrepreneurs\"><\/span>Investment Opportunities for Entrepreneurs<span class=\"ez-toc-section-end\"><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-236a0f0 elementor-widget elementor-widget-text-editor\" data-id=\"236a0f0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>There are several opportunities for entrepreneurs in the biosimilars space, depending on their investment capacity. Full-scale manufacturing is costly but there are smaller opportunities.<\/p><p>For startups and MSMEs, it is not essential to set up a biologics facility. You can build up segments later.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-01f9315 elementor-widget elementor-widget-heading\" data-id=\"01f9315\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"Popular_investment_options_include\"><\/span>Popular investment options include:<span class=\"ez-toc-section-end\"><\/span><\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d7f8580 elementor-widget elementor-widget-text-editor\" data-id=\"d7f8580\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Insulin fill-finish manufacturing units<\/li><li>Contract development and manufacturing (CDMO)<\/li><li>Biologic API production<\/li><li>Cold chain logistics<\/li><li>Bioanalytical testing labs<\/li><\/ul><p>These segments are all key players in the biosimilars value chain, and are prime for growth.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-9646a6b e-flex e-con-boxed e-con e-parent\" data-id=\"9646a6b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a402413 elementor-widget elementor-widget-heading\" data-id=\"a402413\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"Government_Support_Is_a_Big_Advantage\"><\/span>Government Support Is a Big Advantage<span class=\"ez-toc-section-end\"><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0bd6420 elementor-widget elementor-widget-text-editor\" data-id=\"0bd6420\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The Indian government is encouraging the development of biosimilars with incentives and support. This makes it easier for startups to be profitable.<\/p><p>One of the greatest benefits is the Production Linked Incentive (PLI) scheme, which provides incentives for increased sales. There&#8217;s also support with funding through biotech and start-up grants.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a1a5737 elementor-widget elementor-widget-heading\" data-id=\"a1a5737\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"Key_government_support_includes\"><\/span>Key government support includes:<span class=\"ez-toc-section-end\"><\/span><\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6443a17 elementor-widget elementor-widget-text-editor\" data-id=\"6443a17\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Pharmaceuticals PLI Scheme<\/li><li>BIRAC support for biotech startups<\/li><li>Subsidies and biotech parks at the State level<\/li><\/ul><p>Such policy support is beneficial for entrepreneurs.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-eaaae40 elementor-widget elementor-widget-text-editor\" data-id=\"eaaae40\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3 style=\"text-align: center;\"><span class=\"ez-toc-section\" id=\"Identify_high-growth_industries_before_others_do\"><\/span><a href=\"https:\/\/www.niir.org\/startup-selector\" rel=\"nofollow noopener\" target=\"_blank\">Identify high-growth industries before others do<\/a><span class=\"ez-toc-section-end\"><\/span><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-71a088f e-flex e-con-boxed e-con e-parent\" data-id=\"71a088f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0c05f7d elementor-widget elementor-widget-heading\" data-id=\"0c05f7d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"How_Niir_Project_Consultancy_Services_Helps_You_Start\"><\/span>How Niir Project Consultancy Services Helps You Start<span class=\"ez-toc-section-end\"><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bd03b7b elementor-widget elementor-widget-text-editor\" data-id=\"bd03b7b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Setting up a biosimilars business is complicated. It requires technical expertise, regulatory clearances and funding. It can be risky if not done right.<\/p><p>This is where Niir Project Consultancy Services (NPCS) come in.<\/p><p>NPCS has over 45 years of experience in assisting entrepreneurs to establish manufacturing businesses in India. With their experience in biopharmaceutical projects, they are the ideal partner for anyone setting up a biosimilars business.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-39e546e elementor-widget elementor-widget-heading\" data-id=\"39e546e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"They_offer_full_range_services_including\"><\/span>They offer full range services including:<span class=\"ez-toc-section-end\"><\/span><\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-afb76e7 elementor-widget elementor-widget-text-editor\" data-id=\"afb76e7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Detailed Project Reports (DPR)<\/li><li>Market analysis and demand forecasts<\/li><li>Manufacturing process planning<\/li><li>Capital investment and financial analysis<\/li><li>CDSCO\/ USFDA\/ EMA regulatory support<\/li><li>Government support (PLI)<\/li><\/ul><p>NPCS supports entrepreneurs from concept to commercialisation.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ce6b3e8 elementor-widget elementor-widget-text-editor\" data-id=\"ce6b3e8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3 style=\"text-align: center;\"><span class=\"ez-toc-section\" id=\"Related_Article_Biopharma_SHAKTI_Scheme_Explained_%E2%82%B910000_Crore_Government_Push_for_Biologics_Manufacturing\"><\/span>Related Article: <a href=\"https:\/\/www.niir.org\/blog\/biopharma-shakti-scheme-india\/\" rel=\"nofollow noopener\" target=\"_blank\">Biopharma SHAKTI Scheme Explained: \u20b910,000 Crore Government Push for Biologics Manufacturing<\/a><span class=\"ez-toc-section-end\"><\/span><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-2b45955 e-flex e-con-boxed e-con e-parent\" data-id=\"2b45955\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a5bc82a elementor-widget elementor-widget-heading\" data-id=\"a5bc82a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"Future_Outlook_Why_You_Should_Act_Now\"><\/span>Future Outlook: Why You Should Act Now<span class=\"ez-toc-section-end\"><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7fbebb4 elementor-widget elementor-widget-text-editor\" data-id=\"7fbebb4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The coming years will shape the future of the <a href=\"https:\/\/www.entrepreneurindia.co\/blogs\/biopharma-life-sciences\/\">biosimilars market<\/a>. The patent cliffs of many biologic drugs between 2024 and 2030 will increase the demand for biosimilars.<\/p><p>The country is likely to emerge as the biosimilars capital of the world. But so will competition among manufacturers.<\/p><p>That&#8217;s where the need to get in early comes in. Early entrants will be able to get their operations in place, approvals and branding established before the market is saturated.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9cc9cd6 elementor-widget elementor-widget-video\" data-id=\"9cc9cd6\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/youtu.be\\\/DDWWUiniuBU?si=5HzF9Wn77_6j5_oq&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-0424428 e-flex e-con-boxed e-con e-parent\" data-id=\"0424428\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-97cb87a elementor-widget elementor-widget-heading\" data-id=\"97cb87a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e80602d elementor-widget elementor-widget-text-editor\" data-id=\"e80602d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The biosimilars sector in India is on the threshold of its biggest moment. Leveraging on increasing global demand for biosimilars, favourable government policies, and the existing strong manufacturing base in India, this sector provides one of the biggest entrepreneurial opportunities.<\/p><p>Timing, strategic choice of segments and formulation of a right strategy is critical. Niir Project Consultancy Services will assist you to establish the business.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-3318145 e-flex e-con-boxed e-con e-parent\" data-id=\"3318145\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1a0dbe1 elementor-widget elementor-widget-heading\" data-id=\"1a0dbe1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><span class=\"ez-toc-section\" id=\"FAQs\"><\/span>FAQs<span class=\"ez-toc-section-end\"><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0558412 elementor-widget elementor-widget-text-editor\" data-id=\"0558412\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>How much is the minimum investment?<\/strong><\/p><p>It varies by segment. It could be as low as \u20b910-20 crore for small-scale operations and as high as \u20b9150 crore for large-scale biologic manufacturing.<\/p><p><strong>Is this a good business for startups?<\/strong><\/p><p>Yes, particularly in business segments such as API manufacturing, CDMO and logistics, which have lower initial investment than manufacturing.<\/p><p><strong>How long does approval take?<\/strong><\/p><p>The usual time is 4-7 years, but some products can be approved quicker (18-36 months).<\/p><p><strong>Which products are most profitable?<\/strong><\/p><p>Monoclonal antibodies and insulin biosimilars are the most profitable products.<\/p><p><strong>How can NPCS help me?<\/strong><\/p><p>Niir Project Consultancy Services offers comprehensive services like project development, financial assessment, and regulatory advice.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Introduction: India Biosimilars Market India has now graduated from being merely &#8220;the pharmacy of the world&#8221; for generic medicines to also becoming the most favoured country to manufacture high-value, complex drugs \u2013 especially, biosimilars. As the market is set to surpass $1.5 billion by 2030, biosimilars are emerging as a lucrative business opportunity in the [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":7863,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","override":[{"template":"2","parallax":"1","fullscreen":"1","layout":"right-sidebar","sidebar":"default-sidebar","second_sidebar":"default-sidebar","sticky_sidebar":"1","share_position":"topbottom","share_float_style":"share-monocrhome","show_share_counter":"1","show_view_counter":"1","show_featured":"1","show_post_meta":"1","show_post_author":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"0","post_reading_time_wpm":"300","post_calculate_word_method":"str_word_count","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","show_comment_section":"1","number_popup_post":"1","show_author_box":"1","show_post_related":"0","show_inline_post_related":"0"}],"image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post_position":"meta","trending_post_label":"Trending","sponsored_post_label":"Sponsored by","disable_ad":"0"},"jnews_primary_category":[],"jnews_social_meta":[],"jnews_paywall_metabox":{"paragraph_limit":"2","enable_premium_post":"0","enable_free_post":"0","override_paragraph_limit":"0","enable_preview_post":"0","enable_preview_video":"0"},"jnews_override_counter":{"view_counter_number":"0","share_counter_number":"0","like_counter_number":"0","dislike_counter_number":"0"},"footnotes":""},"categories":[1225,1221],"tags":[1850,1852,1849,1851],"class_list":["post-7859","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-industry","category-startup-opportunities","tag-biosimilars-business-india","tag-biosimilars-manufacturing-india","tag-india-biosimilars-market","tag-pharma-startup-opportunities-india"],"_links":{"self":[{"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/posts\/7859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/comments?post=7859"}],"version-history":[{"count":6,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/posts\/7859\/revisions"}],"predecessor-version":[{"id":7869,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/posts\/7859\/revisions\/7869"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/media\/7863"}],"wp:attachment":[{"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/media?parent=7859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/categories?post=7859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.entrepreneurindia.co\/blogs\/wp-json\/wp\/v2\/tags?post=7859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}